Bildkälla: Stockfoto

Evaxion: First Patient Received All Doses - Redeye

Today, Evaxion reported the full EVX-01 dosing of the first patient in the phase II study of EVX-01.

Today, Evaxion reported the full EVX-01 dosing of the first patient in the phase II study of EVX-01.
Börsvärldens nyhetsbrev
ANNONSER